Gene: IRF2BPL
Official Full Name: interferon regulatory factor 2 binding protein likeprovided by HGNC
Gene Summary: This gene encodes a transcription factor that may play a role in regulating female reproductive function. [provided by RefSeq, Jun 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07377 | IRF2BPL Knockout cell line (HeLa) | Human | IRF2BPL | 1:3~1:6 | Negative | Online Inquiry |
KO07378 | IRF2BPL Knockout cell line (HCT 116) | Human | IRF2BPL | 1:2~1:4 | Negative | Online Inquiry |
KO07379 | IRF2BPL Knockout cell line (HEK293) | Human | IRF2BPL | 1:3~1:6 | Negative | Online Inquiry |
KO07380 | IRF2BPL Knockout cell line (A549) | Human | IRF2BPL | 1:3~1:4 | Negative | Online Inquiry |
IRF2BPL Gene Knockout Cell Lines represent a revolutionary advancement in the field of genetic research, providing scientists with invaluable tools for investigating the biological functions of the IRF2BPL gene and its associated pathways. These cell lines have been meticulously engineered to disrupt the normal expression of the IRF2BPL gene, allowing researchers to observe phenotypic changes and elucidate the gene's role in various biological contexts.
The key function of the IRF2BPL knockout cell lines lies in their ability to model diseases and cellular responses that influence immune regulation, apoptosis, and potentially tumorigenesis. By employing CRISPR-Cas9 technology, the knockout process allows for precise gene editing, resulting in the complete ablation of IRF2BPL protein expression. This enables extensive studies on how the loss of this gene affects cellular signaling pathways, gene expression profiles, and overall cellular behavior.
The scientific importance of these knockout cell lines is profound, particularly in the exploration of autoimmune diseases and potential therapeutic targets. These models offer a unique platform for testing hypotheses related to gene function, evaluating drug efficacy, and understanding complex cellular interactions in both in vitro and in vivo settings. Furthermore, their application extends to various disciplines such as cancer biology, infectious diseases, and immunology, making them invaluable in translational research.
What sets IRF2BPL Gene Knockout Cell Lines apart from alternative models is their precise gene targeting, reproducibility, and ease of culture, which facilitate high-throughput screening and consistent experimental conditions. The ability to generate an array of downstream effects through the knockout model adds depth to experimental designs, making it easier for researchers to draw meaningful conclusions.
For researchers and clinicians alike, these cell lines offer a gateway to new discoveries and advancements in understanding both basic biology and disease mechanisms. Their high utility in research environments translates to more efficient experimentation and the potential for accelerated development of novel therapeutic strategies.
Our company specializes in providing cutting-edge biological products and services, ensuring that our offerings are at the forefront of scientific innovation. With a commitment to quality, reproducibility, and support, we empower researchers to tackle the complexities of gene function and regulation with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.